Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilia H Fu

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Expert Opinion on Pharmacotherapy|August 19, 2007
PEG-asparaginaseCecilia H Fu, Kathleen M Sakamoto
Journal of Pediatric Hematology/Oncology|February 20, 2010
Graft-versus-leukemia effect on infant lymphoblastic leukemia relapsed after sibling hematopoietic stem cell transplantationErin E Boatsman, Cecilia H Fu, Sophie X Song, et al.
Journal of Pediatric Hematology/Oncology|June 29, 2016
Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV): An Active Reinduction Regimen for Children With Relapsed Acute Lymphoblastic Leukemia and Asparaginase IntoleranceKee K Yeo, Paul S Gaynon, Cecilia H Fu, et al.
The American Journal of Clinical Nutrition|March 30, 2012
Inverse association between brown adipose tissue activation and white adipose tissue accumulation in successfully treated pediatric malignancyJames S Chalfant, Michelle L Smith, Houchun H Hu, et al.
Blood|October 29, 2014
Obesity is associated with residual leukemia following induction therapy for childhood B-precursor acute lymphoblastic leukemiaEtan Orgel, Jonathan Tucci, Waseem Alhushki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2017
Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631Matthew A Kutny, Todd A Alonzo, Robert B Gerbing, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 16, 2013
Tobacco smoke exposure and the risk of childhood acute lymphoblastic and myeloid leukemias by cytogenetic subtypeCatherine Metayer, Luoping Zhang, Joseph L Wiemels, et al.
Pediatric Blood & Cancer|April 6, 2011
Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: a report from the Children's Oncology GroupMartin A Champagne, Cecilia H Fu, Myron Chang, et al.
Cancer Research|November 4, 2015
A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal EvolutionKyle M Walsh, Adam J de Smith, Helen M Hansen, et al.
Cancers|December 24, 2021
Comparison of the Transcriptomic Signatures in Pediatric and Adult CMLMinyoung Youn, Stephanie M Smith, Alex Gia Lee, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Opinion on Pharmacotherapy|August 19, 2007
PEG-asparaginaseCecilia H Fu, Kathleen M Sakamoto
Journal of Pediatric Hematology/Oncology|February 20, 2010
Graft-versus-leukemia effect on infant lymphoblastic leukemia relapsed after sibling hematopoietic stem cell transplantationErin E Boatsman, Cecilia H Fu, Sophie X Song, et al.
Journal of Pediatric Hematology/Oncology|June 29, 2016
Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV): An Active Reinduction Regimen for Children With Relapsed Acute Lymphoblastic Leukemia and Asparaginase IntoleranceKee K Yeo, Paul S Gaynon, Cecilia H Fu, et al.
The American Journal of Clinical Nutrition|March 30, 2012
Inverse association between brown adipose tissue activation and white adipose tissue accumulation in successfully treated pediatric malignancyJames S Chalfant, Michelle L Smith, Houchun H Hu, et al.
Blood|October 29, 2014
Obesity is associated with residual leukemia following induction therapy for childhood B-precursor acute lymphoblastic leukemiaEtan Orgel, Jonathan Tucci, Waseem Alhushki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2017
Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631Matthew A Kutny, Todd A Alonzo, Robert B Gerbing, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 16, 2013
Tobacco smoke exposure and the risk of childhood acute lymphoblastic and myeloid leukemias by cytogenetic subtypeCatherine Metayer, Luoping Zhang, Joseph L Wiemels, et al.
Pediatric Blood & Cancer|April 6, 2011
Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: a report from the Children's Oncology GroupMartin A Champagne, Cecilia H Fu, Myron Chang, et al.
Cancer Research|November 4, 2015
A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal EvolutionKyle M Walsh, Adam J de Smith, Helen M Hansen, et al.
Cancers|December 24, 2021
Comparison of the Transcriptomic Signatures in Pediatric and Adult CMLMinyoung Youn, Stephanie M Smith, Alex Gia Lee, et al.
Pageof 1